Measles-containing-vaccine second-dose (MCV2) immunization coverage in Tajikistan
Tajikistan: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 79.0% in 2025. ▼ Falling
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Tajikistan, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Tajikistan stood at 79.0%.
That represents a change of down 6.0% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Tajikistan peaked at 98.0% in 2004 and was at its lowest, 59.0%, in 2000.
That places Tajikistan 112th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently falling across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Tajikistan, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 59.0% | — |
| 2001 | 72.0% | +22.0% |
| 2002 | 93.0% | +29.2% |
| 2003 | 94.0% | +1.1% |
| 2004 | 98.0% | +4.3% |
| 2005 | 92.0% | -6.1% |
| 2006 | 96.0% | +4.3% |
| 2007 | 90.0% | -6.2% |
| 2008 | 85.0% | -5.6% |
| 2009 | 91.0% | +7.1% |
| 2010 | 91.0% | +0.0% |
| 2011 | 91.0% | +0.0% |
| 2012 | 90.0% | -1.1% |
| 2013 | 90.0% | +0.0% |
| 2014 | 89.0% | -1.1% |
| 2015 | 84.0% | -5.6% |
| 2016 | 86.0% | +2.4% |
| 2017 | 86.0% | +0.0% |
| 2018 | 84.0% | -2.3% |
| 2019 | 82.0% | -2.4% |
| 2020 | 81.0% | -1.2% |
| 2021 | 79.0% | -2.5% |
| 2022 | 79.0% | +0.0% |
| 2023 | 78.0% | -1.3% |
| 2024 | 79.0% | +1.3% |
| 2025 | 79.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 87.0% | 59.0% | 98.0% | 10 |
| 2010s | 87.3% | 82.0% | 91.0% | 10 |
| 2020s | 79.2% | 78.0% | 81.0% | 6 |
Countries ranked near Tajikistan
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Heat deaths vs projected death rates 887 (2090)
- Un projection of annual infant deaths 1,061 (2100)
- Population ages 0-14, total, annual growth rate 0.7413 % change on previous year (2025)
- Population ages 0-14, total, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, total, per capita 0.3587 units per person (2025)
- Population ages 15-64, female, annual growth rate 2.1 % change on previous year (2025)
- Population ages 15-64, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 15-64, female, per capita 0.3086 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Tajikistan?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Tajikistan was 79.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Tajikistan?
- The highest recorded value was 98.0% in 2004.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Tajikistan?
- The lowest recorded value was 59.0% in 2000.
- How does Tajikistan rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Tajikistan ranks 112th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Tajikistan?
- Over the last ten years it is down 6.0%. The long-run trend across the full record is falling.
- Where does this Tajikistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).